With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

For the multi-dose pen, Eli Lilly submitted a bioequivalence (BE) study conducted in the United States. However, the SEC noted that the study comparing a multi-dose pen with a preservative to the ...

Eli Lilly will launch studies to investigate whether its weight loss medications can help control addictive behaviors such as smoking and alcohol and drug abuse, CEO Dave Ricks revealed in a Dec ...

In this article, we are going to take a look at where Eli ... Lilly introduced new vial formats for Zepbound and Mounjaro, which improve accessibility and reduce supply strain on injection pens.

Eli Lilly (LLY) has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound. Ro is joining other telehealth platforms and Amazon Pharmacy ...

Eli Lilly will start studying its obesity products as treatments for alcohol, nicotine, and drug abuse, making it the first major drugmaker to do so, CEO David Ricks said yesterday at an event.

Dec 11 (Reuters) - Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's (LLY.N), opens new tab weight-loss drug Zepbound to patients with obesity, becoming the ...

For a drug that has been on the market for only a year, Eli Lilly and Co.’s anti ... and diabetes treatment Trulicity ($7.4 billion). Lilly diebetes drug Mounjaro, which uses the same active ...

NEW YORK – After patients with estrogen receptor (ER)-positive advanced breast cancer develop resistance to frontline hormone therapy due to ESR1 mutations, treatment with Eli Lilly's imlunestrant ...